切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2024, Vol. 13 ›› Issue (04) : 450 -455. doi: 10.3877/cma.j.issn.2095-3232.2024.04.002

所属专题: 述评 综述

述评

坏死性胰腺炎相关并发症外科干预策略
于泽1, 隋宇航1, 孙备1,()   
  1. 1. 150001 哈尔滨医科大学附属第一医院胰胆外科 肝脾外科教育部重点实验室
  • 收稿日期:2024-02-27 出版日期:2024-08-10
  • 通信作者: 孙备
  • 基金资助:
    国家自然科学基金(82270665,82070658); 黑龙江省自然科学基金团队项目(TD2021H001)

Surgical interventions for necrotizing pancreatitis-related complications

Ze Yu1, Yuhang Sui1, Bei Sun1,()   

  1. 1. Department of Hepatobiliary Surgery, Key Laboratory of Liver and Spleen Surgery of the Ministry of Education, the First Affiliated Hospital of Harbin Medical University, Harbin 150001, China
  • Received:2024-02-27 Published:2024-08-10
  • Corresponding author: Bei Sun
引用本文:

于泽, 隋宇航, 孙备. 坏死性胰腺炎相关并发症外科干预策略[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 450-455.

Ze Yu, Yuhang Sui, Bei Sun. Surgical interventions for necrotizing pancreatitis-related complications[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(04): 450-455.

坏死性胰腺炎(NP)因病程中发生相关并发症而致病情复杂多变、处理困难棘手。外科医师身为MDT团队中的关键角色,如何恰当选择干预的指征及时机,从而避免患者干预不足或干预过度成为临床治疗中的重点和难点。除此之外,在胰腺炎多元化干预模式的背景下,临床医师如何依据患者病情发展特点为其选择具有个体化、专业化的治疗方案,并有效控制副损伤、提高患者整体治愈率也是当今NP治疗的重中之重。笔者结合临床实践,就NP相关并发症的外科干预策略进行探讨,旨在进一步改善该类患者的临床预后。

Necrotizing pancreatitis (NP) is a complicated and challenging condition due to the incidence of NP-related complications over the course of disease. As a key role of MDT team, how to properly select the indications and timing of interventions, thereby avoiding insufficient or excessive interventions for patients, has become the key and challenging task in clinical treatment for surgeons. In addition, under the background of diversified intervention models for pancreatitis, how to choose individualized and professional treatment regimens according to the disease progression characteristics of patients, effectively control secondary injury and improve the overall cure rate are also the top priorities of existing treatment for NP. In this article, surgical interventions for NP-related complications were illustrated combined with clinical practice, aiming to improve clinical prognosis of these patients.

[1]
Lankisch PG, Apte M, Banks PA. Acute pancreatitis[J]. Lancet, 2015, 386(9988):85-96.
[2]
Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus[J]. Gut, 2013, 62(1):102-111.
[3]
李非, 曹锋. 中国急性胰腺炎诊治指南(2021)[J]. 中国实用外科杂志, 2021, 41(7):739-746.
[4]
Forsmark CE, Swaroop Vege S, Wilcox CM. Acute pancreatitis[J]. N Engl J Med, 2016, 375(20):1972-1981.
[5]
孙备, 李冠群. 微创时代重症急性胰腺炎外科干预的治疗策略[J]. 中华外科杂志, 2019, 57(10):725-729.
[6]
Boxhoorn L, van Dijk SM, van Grinsven J, et al. Immediate versus postponed intervention for infected necrotizing pancreatitis[J]. N Engl J Med, 2021, 385(15):1372-1381.
[7]
He WH, Zhu Y, Zhu Y, et al. The outcomes of initial endoscopic transluminal drainage are superior to percutaneous drainage for patients with infected pancreatic necrosis: a prospective cohort study[J]. Surg Endosc, 2017, 31(7):3004-3013.
[8]
Gardner TB, Coelho-Prabhu N, Gordon SR, et al. Direct endoscopic necrosectomy for the treatment of walled-off pancreatic necrosis: results from a multicenter U.S. series[J]. Gastrointest Endosc, 2011, 73(4):718-726.
[9]
隋宇航, 孙备. 感染性胰腺坏死分型的初探与外科干预策略的再思考[J]. 中华外科杂志, 2021, 59(7):601-607.
[10]
van Brunschot S, Hollemans RA, Bakker OJ, et al. Minimally invasive and endoscopic versus open necrosectomy for necrotising pancreatitis: a pooled analysis of individual data for 1980 patients[J]. Gut, 2018, 67(4):697-706.
[11]
孙备, 冀亮. 重症急性胰腺炎并发感染处理的争议与对策[J]. 中国实用外科杂志, 2018, 38(1):53-56.
[12]
方振, 李非. 急性胰腺炎局部并发症的外科微创治疗[J]. 临床肝胆病杂志, 2022, 38(12):2693-2695.
[13]
Hines OJ, Pandol SJ. Management of severe acute pancreatitis[J]. BMJ, 2019, 367:l6227.
[14]
Ke L, Ni HB, Tong ZH, et al. The importance of timing of decompression in severe acute pancreatitis combined with abdominal compartment syndrome[J]. J Trauma Acute Care Surg, 2013, 74(4):1060-1066.
[15]
Kahl S, Zimmermann S, Genz I, et al. Risk factors for failure of endoscopic stenting of biliary strictures in chronic pancreatitis: a prospective follow-up study[J]. Am J Gastroenterol, 2003, 98(11):2448-2453.
[16]
Regimbeau JM, Fuks D, Bartoli E, et al. A comparative study of surgery and endoscopy for the treatment of bile duct stricture in patients with chronic pancreatitis[J]. Surg Endosc, 2012, 26(10):2902-2908.
[17]
王春友, 龙跃平, 周峰, 等. 重症急性胰腺炎并发结肠梗阻原因分析及处理[J]. 临床外科杂志, 2000(2):92-93.
[18]
Patel R, Choksi D, Chaubal A, et al. Renal vein and inferior vena cava thrombosis: a rare extrasplanchnic complication of acute pancreatitis[J]. ACG Case Rep J, 2016, 3(4):e172.
[19]
Anis FS, Adiamah A, Lobo DN, et al. Incidence and treatment of splanchnic vein thrombosis in patients with acute pancreatitis: a systematic review and meta-analysis[J]. J Gastroenterol Hepatol, 2022, 37(3):446-454.
[20]
Gonzelez HJ, Sahay SJ, Samadi B, et al. Splanchnic vein thrombosis in severe acute pancreatitis: a 2-year, single-institution experience[J]. HPB, 2011, 13(12):860-864.
[21]
Condat B, Pessione F, Helene Denninger M, et al. Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy[J]. Hepatology, 2000, 32(3):466-470.
[22]
Nawacki Ł, Matykiewicz J, Stochmal E, et al. Splanchnic vein thrombosis in acute pancreatitis and its consequences[J]. Clin Appl Thromb Hemost, 2021, 27:10760296211010260.
[23]
Simo KA, Niemeyer DJ, Swan RZ, et al. Laparoscopic transgastric endolumenal cystogastrostomy and pancreatic debridement[J]. Surg Endosc, 2014, 28(5):1465-1472.
[24]
Zhao X, Feng T, Ji W. Endoscopic versus surgical treatment for pancreatic pseudocyst[J]. Dig Endosc, 2016, 28(1):83-91.
[25]
Saul A, Ramirez Luna MA, Chan C, et al. EUS-guided drainage of pancreatic pseudocysts offers similar success and complications compared to surgical treatment but with a lower cost[J]. Surg Endosc, 2016, 30(4):1459-1465.
[26]
Farias GFA, Bernardo WM, De Moura DTH, et al. Endoscopic versus surgical treatment for pancreatic pseudocysts: systematic review and meta-analysis[J]. Medicine, 2019, 98(8):e14255.
[1] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[2] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[3] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[4] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[5] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[6] 张洁, 罗小霞, 余鸿. 系统性免疫炎症指数对急性胰腺炎患者并发器官功能损伤的预测价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 68-71.
[7] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[8] 王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[9] 许杰, 李亚俊, 冯义文. SOX新辅助化疗后腹腔镜胃癌D2根治术与常规根治术治疗进展期胃癌的近期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 647-650.
[10] 刘柏隆, 周祥福. 女性尿失禁吊带手术并发症处理的经验分享[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 127-127.
[11] 嵇振岭, 陈杰, 唐健雄. 重视复杂腹壁疝手术并发症的预防和处理[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 601-606.
[12] 江志鹏, 钟克力, 陈双. 复杂腹壁疝手术后腹腔高压与腹腔间室综合征的预防和处理[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 612-615.
[13] 王学虎, 赵渝. 复杂腹壁疝手术中血管损伤并发症的预防和处理[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 616-619.
[14] 马东扬, 李斌, 陆安清, 王光华, 雷文章, 宋应寒. Gilbert 与单层补片腹膜前疝修补术疗效的随机对照研究[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 629-633.
[15] 王浩源, 汪海洋, 孙建明, 陈以宽, 祁小桐, 唐博. 腹腔镜与开放修补对肝硬化腹外疝患者肝功能及凝血的影响[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 654-659.
阅读次数
全文


摘要